High-dose ibuprofen linked to small increased CV risk, EMA committee confirms
This article was originally published in Scrip
Executive Summary
A European Medicines Agency committee has confirmed that there is a small increase in the risk of cardiovascular problems such as heart attacks and stroke in patients taking high doses – 2,400mg or more – of ibuprofen, and has recommended that the labelling of products containing the anti-inflammatory drug should be updated to reflect this risk.
You may also be interested in...
Russia May Cap Drug Prices In Fight Against COVID-19
As part of its efforts to preserve patient access to medicines amid the COVID-19 pandemic, Russia is planning to cap drug prices if increases of more than 30% are detected. It will also allow online sales of non-prescription drugs and may also tighten the rules on fake and substandard products.
French Clarify Use Of Plaquenil & Kaletra In COVID-19
France is exploring the use of hydroxychloroquine and lopinavir/ritonavir in COVID-19, but only in hospitalized patients and in clinical trials, and has banned all exports of the products to avoid possible shortages.
UK Attacks Pandemic With Funding For Drug And Vaccine Trials
Efforts are under way in the UK on many fronts to develop new treatments and vaccines for coronavirus infection, including researching new uses of existing products and clinical trials of new vaccines.
Need a specific report? 1000+ reports available
Buy Reports